Science Explorer Back to mapMap
Discussion
Researcher · Genexine (South Korea) · South Korea

Minkyu Heo

Minkyu Heo publishes mostly in Oncology, Immunology and Endocrinology, Diabetes and Metabolism, on topics such as Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

ORCID 0009-0007-2041-8104 OpenAlex
World rank
#5,352,819
of 7,710,434 ranked researchers
Rank in South Korea
#97,184
of 162,609
Works
17
Citations
126
Citations per work
7.4
h-index
5
i10-index 5Top 89% in Oncology
Minkyu Heo

What does Minkyu Heo research?

Minkyu Heo's work is mostly in Medicine (49%), Immunology and Microbiology (29%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 8 works · 49.0% of their workMedicine: 8 works · 49.0% of their workOncology: 5 works · 28.6% of their workEndocrinology, Diabetes and Metabolism: 2 works · 14.3% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 6.1% of their workLife Sciences: 6 works · 36.8% of their workImmunology and Microbiology: 5 works · 28.6% of their workImmunology: 5 works · 28.6% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 8.2% of their workGenetics: 1 works · 4.1% of their workMolecular Biology: 1 works · 4.1% of their workEverything else: 2 works · 14.2% of their workTHEIR WORKMinkyu Heo17works
Life Sciences37%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine849.0%
    1. Immunology and Microbiology528.6%
    2. Biochemistry, Genetics and Molecular Biology18.2%
  3. Everything else214.2%
  1. 1Oncology29% of their works
  2. 2Immunology29% of their works
  3. 3Endocrinology, Diabetes and Metabolism14% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Molecular Biology4% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Minkyu Heo's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunity, Cancer, Immune Checkpoint Blockade, Metabolism, PD-1 and PD-L1, Antigen Presentation and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Immunotherapy82 topics
  2. Immunity62 topics
  3. Cancer52 topics
  4. Immune Checkpoint Blockade51 topic
  5. Metabolism52 topics
  6. PD-1 and PD-L151 topic
  7. Antigen Presentation41 topic
  8. CAR T Cells41 topic
  9. Chimeric Antigen Receptor41 topic
  10. Dendritic Cells41 topic
  11. NK Cell Recognition41 topic
  12. Natural Killer Cells41 topic
  13. Fc Receptors31 topic
  14. Foxp331 topic
  15. IGF-131 topic
  16. Insulin-like Growth Factors31 topic
  17. TGF-ß31 topic
  18. Therapeutic Antibodies31 topic
  19. Activation21 topic
  20. Macrophage21 topic

Where does Minkyu Heo work?

Minkyu Heo's main affiliation in the publication record is Genexine (South Korea), South Korea.

How many publications and citations does Minkyu Heo have?

OpenAlex counts 17 works and 126 citations for Minkyu Heo, an h-index of 5, ranking #5,352,819 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Minkyu Heo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.